科创100ETF华夏（588800）近3月新增规模居可比基金头部，机构表示AI硬件、创新药等板块轮动或仍为中报季主旋律

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index (000698) experienced a decline of 0.21% as of July 7, with mixed performance among constituent stocks [1] - The leading gainers included Zhongke Feimiao up 3.84%, Sirui Technology up 3.61%, and Yirui Technology up 3.51%, while the biggest losers were Rongchang Biological down 6.30%, Shengyi Electronics down 4.22%, and Sanjing Guojian down 4.06% [1] - The Huaxia Sci-Tech 100 ETF (588800) fell by 0.10%, with the latest price at 0.98 yuan, and it saw a significant growth of 278 million yuan in scale over the past three months, ranking at the top among comparable funds [1] Group 2 - CITIC Securities indicated that the current market environment resembles that of late 2014, suggesting that a catalyst is needed to ignite the market, potentially from unexpected developments in US-China policies or changes in the tech industry [1] - The report recommends maintaining three strategic focuses during the mid-year earnings season: industries with strong trends like AI and innovative pharmaceuticals, sectors driven by performance and valuation such as North American computing chains, non-ferrous metals, and gaming, and themes related to military and new energy sectors [1] - Overall, the rotation among non-ferrous metals, AI hardware, innovative pharmaceuticals, gaming, and military sectors is expected to be the main theme during the mid-year earnings season [1] Group 3 - According to招商证券, AI is identified as a key driver of the current technological revolution, creating investment opportunities across multiple industries and themes in the A-share market [2] - In July, the peak of earnings forecasts disclosure is anticipated, with both positive and pessimistic earnings expectations being critical for the next phase of A-share investment strategies [2] - The Huaxia Sci-Tech 100 ETF (588800) tracks the Sci-Tech Innovation Board 100 Index, with 80% of holdings being stocks with a market cap below 20 billion, focusing on high-potential targets [2]